HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Altered gene expression in squamous cell carcinoma arising from congenital unilateral linear porokeratosis.

Abstract
Congenital unilateral linear porokeratosis (CULP) is a rare disorder of keratinization that shares clinical and molecular similarities with psoriasis. It also has an increased risk for malignant transformation to cutaneous squamous cell carcinoma (SCC). We investigated the expression of psoriasin, human beta-defensin-2, cathelicidin antimicrobial peptide/LL-37, e-cadherin, involucrin, p16(INK4a) , p53, cyclin D1 and microchromosome maintenance protein 7 in healthy skin and in lesions of psoriasis, CULP and SCC from the same patient. p16(INK4a) was overexpressed in CULP but not in the subsequent SCC. Psoriasin was overexpressed in psoriasis, CULP and SCC compared with healthy skin. Speculatively, p16(INK4a) and psoriasin could be involved in the pathogenesis of CULP. Moreover, psoriasin may play a role in the malignant transformation of CULP to SCC.
AuthorsN Scola, M Skrygan, U Wieland, A Kreuter, T Gambichler
JournalClinical and experimental dermatology (Clin Exp Dermatol) Vol. 37 Issue 7 Pg. 781-5 (Oct 2012) ISSN: 1365-2230 [Electronic] England
PMID22998543 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
Copyright© The Author(s). CED © 2012 British Association of Dermatologists.
Chemical References
  • Biomarkers, Tumor
  • Neoplasm Proteins
  • RNA, Messenger
Topics
  • Adult
  • Biomarkers, Tumor (metabolism)
  • Carcinoma, Squamous Cell (genetics, metabolism)
  • Female
  • Gene Expression
  • Humans
  • Neoplasm Proteins (metabolism)
  • Porokeratosis (genetics, metabolism)
  • Psoriasis (genetics, metabolism)
  • RNA, Messenger (metabolism)
  • Skin (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: